Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
EUDRAC Logo
EUDRAC Growth Score
81
CB Rank
2068414
Heat Score
47
EUDRAC is a regulatory affairs and pharmacovigilance consultancy company that supports driving products through development and publication.
Acquired by
QbD Group Logo
QbD Group
Founded
obfuscation
Private Chalgrove, Oxfordshire, United Kingdom11-50 www.eudrac.com
Medical Device
Pharmaceutical
Overview

EUDRAC
Growth Score
81
Heat Score
47

Growth Score81
-6 pts
in past quarter
Heat Score 47
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About EUDRAC

CB Rank
2068414
EUDRAC is a regulatory affairs and pharmacovigilance consultancy company that supports driving products through development and publication.
Acquired by
QbD Group Logo
QbD Group
Founded
obfuscation
Private Chalgrove, Oxfordshire, United Kingdom11-50 www.eudrac.com
Medical Device
Pharmaceutical

Details

Legal Name EUDRAC Ltd
Operating Status Active
Company Type For Profit
Phone Number 44 (0)1865 670860
Contact Email carole.pugh@eudrac.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Product Development Support
Assistance in driving medicinal products through development phases including clinical trials and regulatory documentation preparation.
Regulatory Affairs Consultancy
Support for regulatory submissions such as Marketing Authorisation Applications, variations, renewals, and lifecycle management of medicinal products.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

on
obfuscation
.
Transaction Name 
EUDRAC acquired by QbD Group Logo
EUDRAC acquired by QbD Group
Acquired by 
QbD Group Logo
QbD Group
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Aug 24, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

174
-92.65%
 in past month

IT Spend

$190.2KThis year, EUDRAC is projected to spend $190.2K on IT, according to Aberdeen.

Actively Used Products

9EUDRAC uses 9 technology products and services including HTML5, Google Fonts, and  DigiCert, according to G2 Stack.

Active Website Tech Count

4EUDRAC is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Facebook Sharer, and  Pinterest.
Sub-Organizations
Frequently Asked Questions

Where is EUDRAC's headquarters? EUDRAC is located in Chalgrove, Oxfordshire, United Kingdom.Who are EUDRAC's competitors? Alternatives and possible competitors to EUDRAC may include BlueReg Group, PharmaRelations, and  PRSG.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|